ANXA1 and melanoma: Moderate/strong expression of all three markers (ANXA1, CAV-1 and EphA2) was found in 21/113 (19 %) of the melanoma samples, 16/77 (21 %) of primary melanoma samples and 5/36 (14 %) of metastatic samples.